Chanjo Kwa Wakati - Improving Vaccination Coverage and Timeliness in Rural Settings
Launched by UNIVERSITY OF SOUTH CAROLINA · Aug 28, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Chanjo Kwa Wakati trial is studying a new way to improve vaccination for young children in rural Tanzania. The goal is to see if a program led by community health workers, which uses text messages (SMS) and other strategies, can help parents get their children vaccinated on time. Researchers are comparing how well this program works against the usual care that families receive. They are particularly focused on making sure that children get all their vaccinations by the time they turn one year old, which is crucial for their health.
To be part of this study, mothers of children aged 12 to 23 months or pregnant women in their last trimester who live in the area of the health facilities can participate. Participants can expect to receive support and information to help them keep track of their children’s vaccinations. This trial is important because it will provide valuable information on how to better promote vaccination in low-resource settings, helping to ensure that more children receive the vaccinations they need for a healthy start in life.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria for the Cross-sectional sample:
- • mothers of children ages 12-23 months
- • residing in the sampling area
- Inclusion Criteria for the Longitudinal sample:
- • pregnant women in their last trimester of pregnancy
- • residing in the sampling area
- • expected to reside in the sampling area until the child reaches age 1 year
- Exclusion Criteria:
- • Women who are not living in catchment areas of participating health facilities (which routinely provide maternal and child health services, including antenatal care and at least weekly routine childhood immunization. Facilities must be operational, must have at least 2 community health workers, and must have reported at least 100 pregnancies or births in the year prior to study implementation.)
About University Of South Carolina
The University of South Carolina (USC) is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a commitment to excellence in research and education, USC leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical investigations aimed at improving patient outcomes and addressing pressing health challenges. Collaborating with a diverse network of healthcare professionals, researchers, and community partners, USC fosters an environment of discovery and translation, ensuring that findings from clinical trials contribute significantly to the advancement of medical science and evidence-based practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dar Es Salaam, , Tanzania
Patients applied
Trial Officials
Jan Ostermann, PhD
Principal Investigator
University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported